• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

JAK inhibitor

Leo
Marketing

Leo roars onto Netflix with DTC campaign for new eczema cream

Having built growth plans on the recently approved medicine, the Danish drugmaker is running a DTC campaign, including an ad on streaming services.
Nick Paul Taylor Mar 5, 2026 10:45am
Leo Pharma lion

FDA signs off on Leo Pharma's chronic hand eczema cream Anzupgo

Jul 24, 2025 8:45am
settlement

Sun launches alopecia med Leqselvi after Incyte settlement

Jul 14, 2025 11:21am
Incyte

Incyte posts mixed Opzelura results in prurigo nodularis

Mar 10, 2025 11:23am
eczema atopic dermatitis Black African American patient skin of color

Incyte's JAK cream Opzelura slows while Leo competition looms

May 3, 2024 10:53am
Incyte

Incyte's Opzelura scores in hidradenitis suppurativa study

Mar 11, 2024 1:58pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings